Приказ основних података о документу

dc.creatorIgnjatović, Aleksandar
dc.creatorStević, Zorica D
dc.creatorLavrnic, Dragana S
dc.creatorNikolić-Kokić, Aleksandra
dc.creatorBlagojević, Duško P
dc.creatorSpasić, Mihajlo
dc.creatorSpasojević, Ivan
dc.date.accessioned2022-04-05T14:34:07Z
dc.date.available2022-04-05T14:34:07Z
dc.date.issued2012
dc.identifier.issn1748-2968
dc.identifier.urihttp://rimsi.imsi.bg.ac.rs/handle/123456789/535
dc.description.abstractALS is characterized by oxidative damage in the brain and cerebrospinal fluid, which is exerted by pro-oxidative activity of iron. Such activity of iron can be drastically increased in the presence of inappropriate iron ligands that catalyze redox cycling of iron, thereby promoting hydroxyl radical generation. The aim of our study was to determine the relative level of inappropriate iron ligands in the cerebrospinal fluid of ALS patients. To determine the levels of inappropriate iron ligands and redox activity of iron in cerebrospinal fluid (10 samples from ALS patients and 10 controls), we applied electron paramagnetic resonance spectroscopy. We have shown that cerebrospinal fluid of ALS patients comprises twofold increased level of inappropriate iron ligands, proportionally increasing iron redox activity and hydroxyl radical production compared to controls. In conclusion, our results strongly support the pro-oxidative/detrimental role of inappropriately chelated iron in ALS pathophysiology. The identification of biomolecules that form such iron complexes and their therapeutic targeting may represent the future of ALS treatment.en
dc.publisherInforma Healthcare, London
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175083/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173014/RS//
dc.rightsrestrictedAccess
dc.sourceAmyotrophic Lateral Sclerosis
dc.subjectoxidative stressen
dc.subjectligandsen
dc.subjectironen
dc.subjectcerebrospinal fluiden
dc.subjectAmyotrophic lateral sclerosisen
dc.titleInappropriately chelated iron in the cerebrospinal fluid of amyotrophic lateral sclerosis patientsen
dc.typearticle
dc.rights.licenseARR
dc.citation.epage362
dc.citation.issue4
dc.citation.other13(4): 357-362
dc.citation.rankM22
dc.citation.spage357
dc.citation.volume13
dc.identifier.doi10.3109/17482968.2012.665929
dc.identifier.pmid22424123
dc.identifier.scopus2-s2.0-84861640240
dc.identifier.wos000304521600005
dc.type.versionpublishedVersion


Документи

ДатотекеВеличинаФорматПреглед

Уз овај запис нема датотека.

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу